脱多不和脂肪酸 缓解在体外由氧化应激引起的骨肌肉功能障碍
bioRxiv : the preprint server for biology
|January 9, 2026
概括
脱多不和脂肪酸 (D-PUFA) 保护肌肉细胞免受氧化应激和脂质过氧化. 这项研究表明,D-PUFA可能是针对肌肉消耗疾病的新疗法策略.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 肌肉生理学 肌肉生理学
背景情况:
- 氧化应激会导致脂质过氧化,导致疾病中的骨肌肉缩.
- 多不和脂肪酸 (PUFA) 对于肌肉细胞膜至关重要,但容易过氧化.
- 目前由于脂质过氧化而导致的肌肉消耗的治疗方法有限.
研究的目的:
- 为了研究是否化PUFAs (D-PUFAs) 可以保护肌肉细胞免受氧化应激.
- 评估D-PUFA在预防肌肉细胞功能障碍和缩方面的潜力.
主要方法:
- 用长链PUFA的原生 (H-) 和化 (D-) 形式 (阿拉基酸,eicosapentaenoic酸,docosapentaenoic酸,docosahexaenoic酸) 处理培养的菌根管.
- 细胞暴露于活性氧物种 (ROS) 或铁灭诱导剂.
- 评估了脂质过氧化水平,肌管生长和抗氧化酶的表达.
主要成果:
- 与H-PUFA不同的是,D-PUFA可以保护肌管免受ROS诱导的脂质过氧化和功能障碍.
- 此外,D-PUFA还可以防止埃拉斯诱导的铁亡,并保持肌体分化.
- D-PUFA调节了内源性抗氧化酶和肌肉特异性蛋白质链酶的表达.
结论:
- 化PUFA限制了它们对脂质过氧化的敏感性.
- 作为一种新的治疗方法,D-PUFA显示出对抗氧化应激诱导的骨肌肉缩的希望.
- 这一策略可以为各种肌肉骨疾病提供新的治疗方法,这些疾病的特征是肌肉消耗.
相关概念视频
Skeletal Muscle Relaxants: Adverse Effects
1.2K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
1.2K
Muscle Recovery and Fatigue
4.5K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
4.5K


